Besides phosphorylation of eIF2α, increased levels of eIF2α expression are detected in tumor samples in bronchioloalveolar carcinomas of the lung, Hodgkin's lymphoma, gastrointestinal carcinomas, malignant melanoma, and melanocytic neoplasms [70, 85]. The gene discussed is EIF2A; the disease is Hodgkins lymphoma.